CAUWENBERGH GEERT (President & CEO) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/20/2019ACC: 0001209191-19-057497
DirectorOfficer· President & CEO
Since Aug 2018
+225K
Net shares
Net buyer
$22.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
225K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
+225K
Price / share
$0.10
Trade value
$22.50K
% of position
46.9%
11/18/2019
479.84K→704.84K
Total
Net shares
+225K
Net value
$22.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 11/18/2019 | A · Award | +225K | $0.10 | $22.50K | 46.9% | 479.84K | 704.84K |
| Total | +225K | $22.50K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common stock, $0.0001 par value
IndirectShares owned450.00
Total
450.00 indirect450.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock, $0.0001 par value | 450.00 | Indirect |
| Total | 450.00 | 450.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported